ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

42,707Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 210

$3.03M Total Retail Price of All Prescriptions

Rank: 1 out of 210

2,037 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 2,037 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 39,283 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

45% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL SUCCINATE 3,659 3,395 10 1 5
ATORVASTATIN CALCIUM 2,611 2,422 10 2 6
AMLODIPINE BESYLATE 1,557 1,470 3 4
ATENOLOL 1,469 1,336 4 12
SIMVASTATIN 1,424 1,306 5 2
DIOVAN HCT 1,390 1,317 10 6 26
FUROSEMIDE 1,324 1,218 7 8
CRESTOR 1,241 1,096 8 14
WARFARIN SODIUM 1,201 1,119 9 9
PLAVIX 1,174 1,081 10 10 11
CLOPIDOGREL 1,123 1,015 11 10
DIOVAN 1,058 1,018 12 17
CARVEDILOL 893 740 13 1
LIPITOR 880 810 10 14 29
METOPROLOL TARTRATE 871 842 15 7
LISINOPRIL 829 728 16 3
SPIRONOLACTONE 823 770 10 17 24
CLONIDINE HCL 716 675 18 38
AMIODARONE HCL 667 642 10 19 19
LEVOTHYROXINE SODIUM 571 558 20 30
OMEPRAZOLE 470 427 21 31
BENAZEPRIL HCL 461 424 22 28
NIFEDIPINE ER 455 455 23 44
TAMSULOSIN HCL 442 399 24 55
METFORMIN HCL 428 374 25 34
NIASPAN 411 343 26 35
HYDROCHLOROTHIAZIDE 360 288 27 18
LOSARTAN POTASSIUM 348 311 28 13
EFFIENT 333 220 29 37
AMLODIPINE BESYLATE-BENAZEPRIL 333 287 29 60
PRADAXA 314 310 31 22
LOSARTAN-HYDROCHLOROTHIAZIDE 311 293 32 36
SINGULAIR 310 282 33 80
NEXIUM 277 272 34 67
DIGOXIN 276 257 35 16
ZETIA 275 246 36 23
RAMIPRIL 269 235 37 27
ISOSORBIDE MONONITRATE ER 266 256 38 15
SERTRALINE HCL 262 239 39 73
TRICOR 246 218 40 70
BENICAR 244 204 41 51
PANTOPRAZOLE SODIUM 239 228 42 46
FENOFIBRATE 231 213 43 48
JANUVIA 220 192 44 63
BYSTOLIC 217 209 45 32
NITROSTAT 196 190 46 25
RANEXA 195 178 47 33
MICARDIS HCT 192 183 48 108
PRAVASTATIN SODIUM 191 180 49 21
MULTAQ 191 178 49 49
LOVAZA 188 165 51 43
DEXILANT 171 168 52 92
LYRICA 169 166 53 105
COREG CR 166 160 54 54
VYTORIN 157 156 55 40
BENICAR HCT 155 150 56 84
EXFORGE 151 137 57 65
METOLAZONE 150 139 58 92
PREDNISONE 143 140 59 119
HYDROCODONE-ACETAMINOPHEN 133 116 S3 60 42
DONEPEZIL HCL 130 117 61 64
ZOLPIDEM TARTRATE 130 99 61 47
SPIRIVA 123 123 63 72
VALSARTAN-HYDROCHLOROTHIAZIDE 122 115 64 125
GLIPIZIDE 120 101 65 82
ADVAIR DISKUS 120 94 65 87
AVODART 117 117 67 111
NIFEDICAL XL 116 114 68 102
MONTELUKAST SODIUM 112 102 69 128
CILOSTAZOL 111 103 70 41
ALLOPURINOL 109 89 71 75
GLYBURIDE 106 96 R 72 131
XARELTO 101 95 73 57
SYNTHROID 98 98 74 99
GABAPENTIN 98 83 74 53
ESCITALOPRAM OXALATE 95 95 76 135
THEOPHYLLINE 89 89 77 136
AZOR 89 88 77 112
ACTOS 89 87 77 84
DILTIAZEM 24HR CD 88 88 80 58
TRAMADOL HCL 84 68 81 81
POTASSIUM CHLORIDE 84 84 81 20
ENALAPRIL MALEATE 81 70 83 79
GLYBURIDE-METFORMIN HCL 81 81 R 83 138
PRANDIN 80 80 85 140
PAROXETINE HCL 75 62 86 122
FAMOTIDINE 72 68 87 71
GLIMEPIRIDE 69 65 88 74
PROAIR HFA 67 67 89 109
MECLIZINE HCL 66 48 90 121
LEVOFLOXACIN 64 62 91 113
TRILIPIX 63 63 92 86
PRIMIDONE 63 63 92 150
LANSOPRAZOLE 59 59 94 157
BENAZEPRIL-HYDROCHLOROTHIAZIDE 58 54 95 103
VOLTAREN 57 57 96 120
NAMENDA 53 53 97 90
SUCRALFATE 52 37 98 170
EXFORGE HCT 52 41 98 91
COUMADIN 52 35 98 100
NITROLINGUAL 52 47 98 170
PROPRANOLOL HCL 51 51 102 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.